SAGES Magazine

Trustan esomeprazole TRUSTAN 1,2 * Reference: 1. Miner PB, Katz PO, Chen Y, et al . reanalysis of intragastric pH results based on update correction factors for slimline* and Zinerics TM 24 single-use Ph catheters. American Journal of Gastroenterology . 2006; 1 : 4004-405 2. Miner P Jr, Katz PO, Chen Y, et al . Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: A five-way crossover study. Am J Gastroenterol 2003; 98 :2616 -20. TRUSTAN 20 mg (Gastric resistant tablet). Reg. No: 45/11.4.3/0777. TRUSTAN 40 mg (Gastric resistant tablet). Reg. No: 45/11.4.3/0778. Each gastric resistant tablet contains 20 mg or 40 mg esomeprazole (as magnesium trihydrate) in the form of a multiple unit pellet system (MUPS). PHARMACOLOGICAL CLASSIFICATION:A11.4.3 Medicines acting on gastro-intestinal tract. Other. INDICATIONS: TRUSTAN tablets are indicated for: Gastro-oesophageal Reflux Disease (GORD) - treatment of erosive reflux oesophagitis; long-term management of patients with healed oesophagitis to prevent relapse; symptomatic treatment of GORD. Patients requiring continued non-steroidal anti-inflammatory drug (NSAID) therapy - prevention of gastric and duodenal ulcers associated with NSAID therapy in patients at risk. Incombinationwithappropriateantibacterial therapeutic regimens for theeradicationof Helicobacterpylori -healingof Helicobacterpylori associatedduodenalulcer;preventionof relapseofpepticulcers inpatientswithHelicobacterpyloriassociatedulcerdisease.TRUSTAN has been used in pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion. For full prescribing information refer to the professional information approved by the medicines regulatory authority (04/2014).Trademarks are owned by or licensed to theAspen Group of companies. © 2019Aspen Group of companies or its licensor.All rights reserved.Applicant:AstraZeneca Pharmaceuticals (Pty) Ltd. Co. Reg. No. 1992/005854/07. Building 2, Northdowns Office Park, 17 Georgian Crescent West, Bryanston, 2191. Private Bag X23, Bryanston, 2021. Tel: +27 (0) 11 797-6000. Fax: +27 (0) 11 797-6001. www.astrazeneca.co.za. Trustan is a registered trademark of the AstraZeneca group of companies. Expiry date: March 2021. Log No.: TRT03/19/004. ZAR-TRT-0319-2672 03/19 rustan esomeprazole TRUSTAN 1,2 * eference: 1. Miner PB, Katz PO, Chen Y, et al . reanalysis of intragastric pH results based on update correction factors for slimline* and Zinerics TM 24 single-use Ph catheters. American Journal of Gastroenterology . 2006; 1 : 4004-405 2. Miner P Jr, Katz PO, Chen Y, et al astric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: A five-way crossover study. Am J Gastroenterol 2003; 98 :2616 -20. TRUSTAN 20 mg (Gastric resistant tablet). Reg. No: 45/11.4.3/0777. TRUSTAN 40 mg (Gastric resistant tablet). Reg. No: 45/11.4.3/0778. Each gastric resistant tablet contains 20 mg or 40 mg esomeprazole (as magnesium trihydrate) in the form of a multiple uni ellet system (MUPS). PHARMACOLOGICAL CLASSIFICATION: A 11.4.3 Medicines acting on gastro-intestinal tract. Other. INDICATIONS: TRUSTAN tablets are indicated for: Gastro-oesophageal Reflux Disease (GORD) - treatment of erosive reflux oesophagitis; long-ter anagement of patients with he led esophagitis to prev nt relaps ; sympt matic treatme t of GORD. Patients requiring continued non-steroidal anti-inflammatory drug (NSAID) therapy - prevention of gastric and duodenal ulcers associate with NSAID therapy in patients a isk. Incombinationwithappropriateantibacterial therapeutic regimens for the radicationof Helicobacter ylori -healingof Helic bacterpylori associatedduodenalulcer;preventionof relapseofp pticulc rs inpatientswithHelicobacterpyloriassociatedulcerdisease.TRUSTAN as been used i pathological hypersecretory co ditions including Zollinger-Ellison synd ome a d idiopat ic hyp rs cretion. For full pr scribing informa on refer to the prof ssional information approved by the medici es regulatory auth ity (04/2014). Trademarks are owned by r licensed to the Asp n Group of compa ies. © 2019 Aspen Group of companies or its licensor. All right es rved Applicant: AstraZeneca Pha maceuticals (Pty) Ltd. Co. Reg. No. 1992/005854/07. Building 2, Northd wns Office Park, 17 Georgian Crescent West, Bryanston 191. Private Bag X23, Bryanston, 2021. Tel: +27 (0) 11 797-6000. Fax: +27 (0) 11 797-6001. www.astrazeneca.co.za. Trustan is a registered trademark of the AstraZeneca group of companies. Expiry date: March 2021. Log No.: TRT03/19/004. ZAR-TRT-0319-2672 03/1 from the same cloth... Reference: 1. Medikredit data Ju e 2020. TRUSTAN 20 mg . Reg. No. 45/11.4.3/0777. Each gastric resistant tablet contains 20 mg esomeprazole (as magnesium trihydrate) in the form of a multiple unit pellet system (MUPS). TRUSTAN 40 mg . Reg. No. 45/11.4.3/0778. Each gastric resistant tablet contains 40 mg esomeprazole (as magnesium trihydrate) in the form of a multiple unit pellet system (MUPS). For full prescribing information refer to the professional information approved by the medicines regulatory uthority (04/2014). Trad marks are owned by or licensed t the Aspen Gro p of companies. © 2020 Aspen Group of comp nies or its licen or. All rights reserved. Marketed by Ethicare, a division of Pharmacare Limited. Co. Reg. No.: 1898/000252/06. Healthcare Park, Woodlands Drive, Woodmead, 2191. ZAR-ESO-11-20-00001 11/20 CLONE of the only The originator 1 A division of Pharmacare Limited t/a Aspen Pharmacare. Medical Careline - 0800 CARE 02 (0800 227 302)